Recent advancement, immune responses, and mechanism of action of various vaccines against intracellular bacterial infections

A Ali, A Waris, MA Khan, M Asim, AU Khan, S Khan… - Life Sciences, 2023 - Elsevier
Emerging and re-emerging bacterial infections are a serious threat to human and animal
health. Extracellular bacteria are free-living, while facultative intracellular bacteria replicate …

[HTML][HTML] Shigella outer membrane vesicles as promising targets for vaccination

M Qasim, M Wrage, B Nüse, J Mattner - International Journal of Molecular …, 2022 - mdpi.com
The clinical symptoms of shigellosis, a gastrointestinal infection caused by Shigella spp.
range from watery diarrhea to fulminant dysentery. Endemic infections, particularly among …

[HTML][HTML] Production of highly immunogenic and safe Triton X-100 produced bacterial ghost vaccine against Shigella flexneri 2b serotype

A Abdelfattah, R Samir, HM Amin - Gut Pathogens, 2023 - Springer
Abstract Background Bacterial ghost cells (BGCs) are cells were drained of their genetic and
cytoplasmic components. This work aimed to develop vaccine candidates against the …

Expression and purification of TolC as a recombinant protein vaccine against Shigella flexneri and evaluation of immunogenic response in mice

R Veisi, S Nazarian, J Fathi, N Hadi - Microbial Pathogenesis, 2024 - Elsevier
Background Shigella is one of the major causes of dysenteric diarrhea, which is known
shigelosis. Shigelosis causes 160,000 deaths annually of diarrheal disease in the global …

Outer membrane vesicles derived from salmonella enterica serotype typhimurium can deliver Shigella flexneri 2a O-polysaccharide antigen to prevent Shigella …

H Tian, B Li, T Xu, H Yu, J Chen, H Yu… - Applied and …, 2021 - Am Soc Microbiol
Shigellosis has become a serious threat to health in many developing countries due to the
severe diarrhea it causes. Shigella flexneri 2a is the principal species responsible for this …

[HTML][HTML] Recent Progress in Shigella and Burkholderia pseudomallei Vaccines

I Chapartegui-González, S Bowser, AG Torres… - Pathogens, 2021 - mdpi.com
Significant advancement has been made in the development of vaccines against bacterial
pathogens. However, several roadblocks have been found during the evaluation of vaccines …

A lactococcus lactis-vectored oral vaccine induces protective immunity of mice against enterotoxigenic escherichia coli lethal challenge

J Song, L Zhao, M Song - Immunology Letters, 2020 - Elsevier
Enterotoxigenic Escherichia coli (ETEC) is a global primary pathogenic bacterium causing
diarrhoea in human and a wide variety of neonatal animals. Lactococcus lactis as non …

[HTML][HTML] Plasmid Replicons for the Production of Pharmaceutical-Grade pDNA, Proteins and Antigens by Lactococcus lactis Cell Factories

SOD Duarte, GA Monteiro - International Journal of Molecular Sciences, 2021 - mdpi.com
The Lactococcus lactis bacterium found in different natural environments is traditionally
associated with the fermented food industry. But recently, its applications have been …

Immunogenicity and protective efficacy of a multi-epitope recombinant toxin antigen of Pasteurella multocida against virulent challenge in mice

W Liang, H Xiao, JY Chen, YF Chang, SJ Cao, YP Wen… - Vaccine, 2023 - Elsevier
Pasteurella multocida (P. multocida) infection frequently results in porcine atrophic rhinitis
and swine plague, leading to large economic losses for the swine industry worldwide. P …

[HTML][HTML] EpiMix Based Novel Vaccine Candidate for Shigella: Evidence of Prophylactic Immunity in Balb/c Mice

H Padh, B Yagnik, D Sharma, P Desai - International Journal of Peptide …, 2021 - Springer
Multidrug resistant Shigella is one of the leading causes of mortality in children and infants.
Availability of vaccine could prevent the Shigella infection and reduce the mortality …